ScoreWhy is Boston Scientific Corp. ?
1
Healthy long term growth as Net Sales has grown by an annual rate of 12.73%
- OPERATING CASH FLOW(Y) Highest at USD 4,285 MM
- ROCE(HY) Highest at 11.71%
- NET SALES(Q) Highest at USD 5,061 MM
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Boston Scientific Corp. should be less than 10%
- Overall Portfolio exposure to Retailing should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Retailing)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Boston Scientific Corp. for you?
Low Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Boston Scientific Corp.
-29.97%
0.77
23.90%
S&P 500
14.9%
0.70
20.15%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
15.16%
EBIT Growth (5y)
46.76%
EBIT to Interest (avg)
5.69
Debt to EBITDA (avg)
2.84
Net Debt to Equity (avg)
0.47
Sales to Capital Employed (avg)
0.52
Tax Ratio
18.32%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
94.32%
ROCE (avg)
6.99%
ROE (avg)
7.79%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
36
Industry P/E
Price to Book Value
5.03
EV to EBIT
32.25
EV to EBITDA
24.14
EV to Capital Employed
3.91
EV to Sales
6.54
PEG Ratio
0.44
Dividend Yield
NA
ROCE (Latest)
12.12%
ROE (Latest)
13.88%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
Bullish
Bullish
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend21What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 4,534 MM
NET PROFIT(HY)
At USD 1,634.64 MM has Grown at 95.93%
ROCE(HY)
Highest at 12.6%
NET SALES(Q)
Highest at USD 5,286 MM
INTEREST COVERAGE RATIO(Q)
The company hardly has any interest cost
OPERATING PROFIT(Q)
Highest at USD 1,577 MM
RAW MATERIAL COST(Y)
Fallen by -17.27% (YoY
DEBTORS TURNOVER RATIO(HY)
Highest at 7.32 times
OPERATING PROFIT MARGIN(Q)
Highest at 29.83 %
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Here's what is working for Boston Scientific Corp.
Net Profit
At USD 1,634.64 MM has Grown at 95.93%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very positive
Net Profit (USD MM)
Operating Cash Flow
Highest at USD 4,534 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Net Sales
Highest at USD 5,286 MM and Grown
In each period in the last five periodsMOJO Watch
Near term sales trend is very positive
Net Sales (USD MM)
Operating Profit
Highest at USD 1,577 MM and Grown
In each period in the last five periodsMOJO Watch
Near term Operating Profit trend is quite positive
Operating Profit (USD MM)
Operating Profit Margin
Highest at 29.83 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Debtors Turnover Ratio
Highest at 7.32 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -17.27% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
Highest at USD 365 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (USD MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
